161 related articles for article (PubMed ID: 16006799)
1. Allelic loss in parathyroid neoplasia can help characterize malignancy.
Hunt JL; Carty SE; Yim JH; Murphy J; Barnes L
Am J Surg Pathol; 2005 Aug; 29(8):1049-55. PubMed ID: 16006799
[TBL] [Abstract][Full Text] [Related]
2. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
Yip L; Seethala RR; Nikiforova MN; Nikiforov YE; Ogilvie JB; Carty SE; Yim JH
Surgery; 2008 Dec; 144(6):949-55; discussion 954-5. PubMed ID: 19041002
[TBL] [Abstract][Full Text] [Related]
4. Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma.
Chang YJ; Mittal V; Remine S; Manyam H; Sabir M; Richardson T; Young S
Am Surg; 2006 May; 72(5):419-26. PubMed ID: 16719197
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
Haven CJ; van Puijenbroek M; Karperien M; Fleuren GJ; Morreau H
J Pathol; 2004 Jan; 202(1):86-94. PubMed ID: 14694525
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Tanaka A; Kanazawa K; Ogura M; Ebuchi M; Takizawa T; Funata N; Fukayama M
Lab Invest; 1999 Sep; 79(9):1051-8. PubMed ID: 10496523
[TBL] [Abstract][Full Text] [Related]
7. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
8. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
[TBL] [Abstract][Full Text] [Related]
9. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
10. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
[TBL] [Abstract][Full Text] [Related]
11. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness.
Hunt JL; Livolsi VA; Baloch ZW; Swalsky PA; Bakker A; Sasatomi E; Finkelstein S; Barnes EL
Hum Pathol; 2003 Apr; 34(4):375-80. PubMed ID: 12733119
[TBL] [Abstract][Full Text] [Related]
12. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
[TBL] [Abstract][Full Text] [Related]
14. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features.
Yoshimoto K; Endo H; Tsuyuguchi M; Tanaka C; Kimura T; Iwahana H; Kato G; Sano T; Itakura M
Clin Endocrinol (Oxf); 1998 Jan; 48(1):67-72. PubMed ID: 9509070
[TBL] [Abstract][Full Text] [Related]
15. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
16. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of parathyroid neoplasia by gene expression profiling.
Morrison C; Farrar W; Kneile J; Williams N; Liu-Stratton Y; Bakaletz A; Aldred MA; Eng C
Am J Pathol; 2004 Aug; 165(2):565-76. PubMed ID: 15277230
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
19. Genetic abnormalities in parathyroid nodules of uremic patients.
Chudek J; Ritz E; Kovacs G
Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
